Expression and function of the purinergic receptor P2X7 in patients with pulmonary tuberculosis

S Franco-Martínez1, P Niño-Moreno, S Bernal-Silva

  • 1Department of Immunology, Facultad de Medicina, UASLP, San Luis Potosí, SLP, Mexico.

Insights

Tuberculosis patients show altered gene expression in response to adenosine triphosphate (ATP), suggesting a defective P2X(7) channel receptor function crucial for fighting Mycobacterium tuberculosis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Infectious Diseases

Background:

  • P2X(7) receptor is an ATP-gated ion channel involved in host defense against intracellular pathogens.
  • Mycobacterium tuberculosis infection, causing tuberculosis (TB), poses a significant global health challenge.
  • Understanding immune cell function in TB is critical for developing effective treatments.

Purpose of the Study:

  • To investigate the role of the P2X(7) receptor in immune responses during pulmonary tuberculosis.
  • To compare P2X(7) expression and function in patients with TB and healthy controls.

Main Methods:

  • Flow cytometry to assess P2X(7) expression on peripheral blood mononuclear cells (PBMC).
  • Analysis of P2X(7) mRNA levels.
  • Functional assays including ATP-induced apoptosis, Lucifer yellow uptake, and ERK phosphorylation.
  • mRNA macroarray analysis of gene expression changes upon ATP stimulation.

Main Results:

  • P2X(7) expression levels were similar, but mRNA levels were higher in TB patients.
  • No significant differences in P2X(7) functional assays (apoptosis, dye uptake, ERK phosphorylation) between groups.
  • ATP stimulation induced a higher number of cytokine genes and fewer apoptosis genes in TB patients' PBMC compared to controls.

Conclusions:

  • TB patients exhibit distinct ATP-induced gene expression patterns in PBMC, despite normal P2X(7) expression and basic function.
  • These findings suggest a potential P2X(7) functional defect in TB patients' immune cells.
  • This defect may impair the ability to control Mycobacterium tuberculosis infection.

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...